scholarly journals Serological Testing Reveals the Hidden COVID-19 Burden among Health Care Workers Experiencing a SARS-CoV-2 Nosocomial Outbreak

Author(s):  
Yu Nakagama ◽  
Yuko Komase ◽  
Katherine Candray ◽  
Sachie Nakagama ◽  
Fumiaki Sano ◽  
...  

We describe the results of testing frontline health care workers, from a hospital in Japan that had experienced a COVID-19 outbreak, for SARS-CoV-2-specific antibodies. Antibody testing revealed that a surprising 42% of overlooked COVID-19 diagnoses occurred when case detection relied solely on PCR-based viral detection.

Author(s):  
Mai-Chi Trieu ◽  
Amit Bansal ◽  
Anders Madsen ◽  
Fan Zhou ◽  
Marianne Sævik ◽  
...  

Abstract Background During the coronavirus disease 2019 (COVID-19) pandemic, many countries experienced infection in health care workers (HCW) due to overburdened health care systems. Whether infected HCW acquire protective immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unclear. Methods In a Norwegian prospective cohort study, we enrolled 607 HCW before and after the first COVID-19 wave. Exposure history, COVID-19–like symptoms, and serum samples were collected. SARS-CoV-2–specific antibodies were characterized by spike-protein IgG/IgM/IgA enzyme-linked immunosorbent and live-virus neutralization assays. Results Spike-specific IgG/IgM/IgA antibodies increased after the first wave in HCW with, but not in HCW without, COVID-19 patient exposure. Thirty-two HCW (5.3%) had spike-specific antibodies (11 seroconverted with ≥4-fold increase, 21 were seropositive at baseline). Neutralizing antibodies were found in 11 HCW that seroconverted, of whom 4 (36.4%) were asymptomatic. Ninety-seven HCW were tested by reverse transcriptase polymerase chain reaction (RT-PCR) during follow-up; 8 were positive (7 seroconverted, 1 had undetectable antibodies). Conclusions We found increases in SARS-CoV-2 neutralizing antibodies in infected HCW, especially after COVID-19 patient exposure. Our data show a low number of SARS-CoV-2–seropositive HCW in a low-prevalence setting; however, the proportion of seropositivity was higher than RT-PCR positivity, highlighting the importance of antibody testing.


2021 ◽  
Author(s):  
Aboobacker Mohamed Rafi ◽  
Maglin Monica Lisa Joseph Tomy ◽  
Ronnie Thomas ◽  
Chithra Valsan ◽  
U G Unnikrishnan ◽  
...  

AbstractBackgroundKerala was the first state to have the confirmed case of COVID-19 in the country and it was first confirmed in Thrissur district on 30 January2020.Our institute being in the heart of the city had to take adequate measures to mitigate the spread and treat the required patients by keeping its staff safe & Healthy. The hallmark of COVID 19 infection is high infectivity, pre-symptomatic transmission and asymptomatic prevalence which could result in high cumulative numbers of infections, hospitalizations, and deaths. Kerala was the first state to confirm community transmission in July 2020.Health care workers being in the forefront in the war against COVID19 are very prone in acquiring the infection and are possible to be asymptomatic sources for cluster formation. Knowing the development of immunity as shown by the presence of anti COV2 antibodies in the population contributes to the epidemiological understanding of the disease. The intent of the study is to do an antibody testing in our hospital to find the serosurveillance of SARS CoV 2 among the healthcare workers in our hospital.AimTo estimate the seropositivity of SARS CoV 2 among the healthcare workers at Jubilee Mission Medical College and Research Institute, Thrissur, Kerala, six months after revoking the lockdownMethodologyA cross sectional study among the health care workers of the medical college. Multistage Sampling was done with the hospital block as the first stage and departments as the second stage. In the final stage of sampling the test individuals were selected on a first come first served basis after the antibody test availability was declared open and free for all staff. A consent form and a Google form were given to all staff who volunteered for participating in the study. Each consented participant recruited into the investigation completed a questionnaire which covers details regarding demographics, exposure history, Residence & travel. Blood sample was collected and Anti-SARS COV2 IgG antibody testing which targets the Spike Protein 1(SP1) was done using the VITROS chemiluminescence platform (Orthoclinical diagnostics, USA). Sampling & testing ranged over a time frame from September 5th to December 15th, 2020ResultsJubilee Mission Medical College has 2785 working staff at the time of study. A total of 420 staff consented and their samples were tested. 37 staff members tested positive for COVID-19 antibody, yielding an overall prevalence of 8.75% (95% CI, 6.23–11.86). 86.5 % (32/37) of them were having a history of COVID-19 Antigen / RT PCR Positivity. We identified a statistically significant linear trend (p value =0.00001), between seropositivity and the degree of severity of COVID 19. Among the various factors which increase the risk of seroconversion, history of undergoing quarantine (p value < 0.001), contact with a confirmed case (p value = 0.002), contact with a caregiver for COVID 19 (p value =0.001) and history of Upper respiratory symptoms (p value =0.001), were found to be significantly associated with positive serology.ConclusionsThe overall seropositivity in the current study was found to be 8.75% which is comparable to seroprevalence studies conducted in the United States and Wuhan in China. The pattern of seropositivity across the different category of health workers observed in the present study showed a higher prevalence among nurses. This result is also in agreement with a recent published report from united states. Various measures advised by the national and state health authorities were adequately adhered to. Keeping track of the pattern of development of immunity in the community is part of understanding the illness and forecasting the spread. For the tested HCW, it will boost up morale by ending uncertainty. For the hospital administration it will help in decision making about relative focusing of interventions on patients in general and HCWs. By knowing the immunity status of HCWs, the Institution will be able to contribute authentically to the development of intervention strategies and guidelines from time to time, besides following the available guidelines. Being an educational institution, it is obligatory to train all the elements of care delivery to the future generation of health care workers. Getting experienced from a small but relevant sample was expected to facilitate larger community study envisaged in peripheral areas Jubilee served


2019 ◽  
Vol 47 (6) ◽  
pp. 683-687 ◽  
Author(s):  
Kerry E. Wilson ◽  
Shannon M. Wood ◽  
Kurt E. Schaecher ◽  
Karen B. Cromwell ◽  
Joan Godich ◽  
...  

2021 ◽  
Vol 10 (1) ◽  
Author(s):  
Lillian R. Talbot ◽  
Jamie L. Romeiser ◽  
Eric D. Spitzer ◽  
Tong J. Gan ◽  
Sunitha M. Singh ◽  
...  

Abstract Background Health care workers (HCW) such as anesthesiologists, surgeons, and intensivists face high rates of exposure to SARS-CoV-2 through direct contact with COVID-19 patients. While there are initial reports of the prevalence of COVID-19 antibodies among the general population, there are few reports comparing the seroprevalence of IgM/IgG COVID-19 antibodies in HCW of different exposure levels as well as different HCW professions. Methods A convenience sample of health care workers provided blood for COVID-19 antibody testing and a review of medical history and work exposure for correlative analyses. Results Overall, 474 HCW were enrolled in April 2020 including 102 front-line physicians (e.g., anesthesiologists, surgeons, intensivists, emergency medicine), 91 other physicians, 135 nurses, 134 other clinical staff, and 12 non-clinical HCW. The prevalence of IgM or IgG antibodies to SARS-CoV-2 was 16.9% (95% CI 13.6–20.6) (80/474). The proportion of positive antibodies in the PCR + group was significantly higher than health care workers without symptoms (84.6% [95% CI 54.6–98.1] vs. 12.3% [95% CI 8.5–17.2], p < 0.001). No significant differences in proportions of COVID-19 antibodies were observed among the different exposure groups (e.g., high vs minimal/no exposure) and among the different HCW professionals. Conclusions Despite exposure to COVID-19 patients, the prevalence of antibodies in our HCW was similar to what has been reported for the general population of New York State (14%) and for another New York HCW cohort (13.7%). Health care workers with higher exposure rates were not more likely to have been infected with COVID-19. Therefore, these data suggest that infection of HCW may result from exposure in the community rather than at work. Trial registration This investigator-initiated study was observational; therefore, no registration was required. Not applicable.


2021 ◽  
Author(s):  
Elizabeth M. Anderson ◽  
Theresa Eilola ◽  
Eileen Goodwin ◽  
Marcus J. Bolton ◽  
Sigrid Gouma ◽  
...  

SUMMARYSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines elicit higher levels of antibodies compared to natural SARS-CoV-2 infections in most individuals; however, the specificities of antibodies elicited by vaccination versus infection remain incompletely understood. Here, we characterized the magnitude and specificity of SARS-CoV-2 spike-reactive antibodies from 10 acutely infected health care workers and 23 participants who received mRNA-based SARS-CoV-2 vaccines. We found that infection and primary mRNA vaccination elicited S1 and S2-reactive antibodies, while secondary vaccination boosted mostly S1 antibodies. Using magnetic bead-based absorption assays, we found that SARS-CoV-2 infections elicited a large proportion of original antigenic sin-like antibodies that bound efficiently to common seasonal human coronaviruses but poorly to SARS-CoV-2. In converse, vaccination only modestly boosted antibodies reactive to common seasonal human coronaviruses and these antibodies bound efficiently to SARS-CoV-2. Our data indicate that SARS-CoV-2 mRNA vaccinations elicit fundamentally different antibody responses compared to SARS-CoV-2 infections.Abstract FigureHIGHLIGHTSSARS-CoV-2 mRNA vaccines elicit higher levels of antibodies compared to SARS-CoV-2 infectionsThe first dose of an mRNA vaccine generates both S1 and S2 responses while the second dose boosts primarily S1-specific antibodiesSARS-CoV-2 infections, but not mRNA vaccinations, elicit high levels of antibodies that bind strongly to seasonal coronaviruses but weakly to SARS-CoV-2


2020 ◽  
Vol 61 (6) ◽  
pp. 485-490
Author(s):  
Ivana Lapić ◽  
Dunja Rogić ◽  
Dragana Šegulja ◽  
Saša Kralik Oguić ◽  
Josip Knežević

2020 ◽  
Vol 7 (Supplement_1) ◽  
pp. S291-S292
Author(s):  
Kathleen Louise Valenzuela ◽  
Jennifer Veltman ◽  
April Wilson

Abstract Background We studied the prevalence of positive SARS-CoV2 antibody and positive SARS-CoV2 antigen among high risk health care workers at Loma Linda University Health System (LLUHS) who voluntarily obtained SARS-CoV2 antibody testing, and if indicated, antigen testing. The study determined that there is a significant decrease in the prevalence of SARS-CoV2 antigen among employees at LLUH compared to the community. Methods Employee Health and Occupational Medicine offered antibody testing to employees who were considered high risk, primarily working in the Coronavirus Disease 19 (COVID-19) designated units. We tested 658 subjects’ serum for the presence of IgM and IgG antibodies via the Nirmidas Qualitative SARS-CoV2 test. 29 subjects with a positive antibody test were subsequently tested for the presence of serum SARS-CoV2 antigen via PCR. Results There were 31 subjects who tested positive for IgM or IgG antibodies. 11 subjects had positive IgM with negative IgG. 3 subjects had negative IgM with positive IgG. 15 patients had positive IgM and positive IgG. 2 subjects had positive IgM with negative IgG, were subsequently retested, and then found to have positive IgM and positive IgG. Of those 31 subjects with a positive antibody test, 2 were not tested for the COVID-19 antigen, 1 had an inconclusive test, 23 tested negative, and 5 tested positive. Of those 5 positive for the antigen, 2 had symptoms and 3 did not report symptoms or did not use the symptom questionnaire. The community prevalence of positive SARS-CoV2 antigen in San Bernardino is 0.37%, as of June 16. The prevalence of positive SARS-CoV2 antigen among LLUH employees is 0.03% and the prevalence of positive antibody is 0.18%. The value of z is -7.3206, p is &lt; .00001. Thus, the result is significant at p &lt; .01. Conclusion The results of this testing supports the efficacy of the early protective measures that LLUHS implemented in preparation for the pandemic. Such protective measures include: mandated face masks, symptoms screening, testing for SARS-CoV2 antibody or antigen on patients admitted, a dedicated COVID-19 section of the emergency department as well as inpatient units, etc. Given the statistical significance of this study, the protective bundle can be used as a template for preventative measures for future pandemics. Disclosures All Authors: No reported disclosures


2021 ◽  
Vol 8 ◽  
pp. 100113
Author(s):  
Le Huu Song ◽  
Nghiem Xuan Hoan ◽  
Mai Hong Bang ◽  
Peter G. Kremsner ◽  
Thirumalaisamy P Velavan

Author(s):  
Mario Plebani ◽  
Andrea Padoan ◽  
Ugo Fedeli ◽  
Elena Schievano ◽  
Elena Vecchiato ◽  
...  

AbstractObjectivesThe ongoing outbreak of coronavirus disease (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses formidable challenges to all health care systems. Serological assays may be used for improving disease management when appropriately applied, for investigating the antibody responses mounted against SARS-CoV-2 infection and for assessing its real prevalence. Although testing the whole population is impractical, well-designed serosurveys in selected subpopulations in specific risk groups may provide valuable information. We evaluated the prevalence of SARS-CoV-2 infection in health care workers (HCW) who underwent molecular testing with reverse transcription real-time polymerase chain reaction (rRT-PCR) in the main hospitals of the Veneto Region of Italy by measuring specific antibodies (Abs).MethodsBoth immunoglobulin (Ig)M and IgG antibodies against SARS-Cov-2 S-antigen and N-protein were measured using a validated chemiluminescent analytical system (CLIA) called Maglumi™ 2000 Plus (New Industries Biomedical Engineering Co., Ltd [Snibe], Shenzhen, China).ResultsA total of 8,285 HCW were tested. SARS-CoV-2 specific antibodies (IgM, IgG or both) were detectable in 378 cases (4.6%, 95% CI 4.1–5.0%). Seroconversion was observed in 4.4% of women vs. 5.0% of men, but this difference was not significant. Although detectable antibodies were found in all HCW who developed severe COVID-19 infection (100%), lower seropositivity was found in mild disease (83%) and the lowest prevalence (58%) was observed in asymptomatic subjects.ConclusionsSeroprevalence surveys are of utmost importance for understanding the rate of population that has already developed antibodies against SARS-CoV-2. The present study defined precisely the circulation of SARS-CoV-2 in a cohort of HCW in the Veneto Region, with its prevalence (4.6%) reflecting a relatively low circulation. Symptomatic individuals or those hospitalized for medical care were 100% antibody positive, whilst Abs were only detectable in 58% of asymptomatic carriers.


Sign in / Sign up

Export Citation Format

Share Document